Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty (TE-EK)
Conditions
Interventions
TE-EK treatment group
Locations
1
Singapore
Singapore Eye Research Institute
Singapore, Singapore
Start Date
December 1, 2017
Primary Completion Date
December 1, 2027
Completion Date
June 1, 2028
Last Updated
September 12, 2025
NCT05436665
NCT02118922
NCT06881771
NCT06652321
NCT03249337
NCT05531760
Lead Sponsor
Singapore Eye Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions